Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The trial protocol used a stepwise escalation schedule, and researchers noted lower discontinuation rates with slower titration
On the general safety profiles of ICI agents, a head-to-head comparison of 36 phase 1 and phase 2 clinical trials that enrolled 15,370 patients found that the safety ranking of ICIs as follows: Atezolizumab (pooled incidence 66.4%, probability 76%), Nivolumab (71.8%, 56%), Pembrolizumab (75.1%, 55%), Ipilimumab (86.8%, 55%) and Tremelimumab (not applicable (NA), 54%)
Toolbox methodology The methodical approach is to select two methods from the toolbox (tables below) that will target front and back impurities from the crude, respectively
For instance, MCT1-mediated lactylation stabilizes HIF-1 and enhances KIAA1199 transcription, thereby facilitating tumor angiogenesis
US$ 21.98
US$ 25.64
US$ 25.10
US$ 29.11
US$ 24.16
US$ 27.32
US$ 26.50
.png?sfvrsn=1e7191c0_3)
US$ 23.88
